MD Anderson Research Highlights for March 9
March 10, 2022
March 10, 2022
HOUSTON, Texas, March 10 (TNSJou) -- The University of Texas's MD Anderson Cancer Center issued the following news release:
* * *
Immunotherapy advances for AML, liver cancer and HPV-related cancers, plus findings related to TIL response, wound repair and proton therapy
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recently published studies in basic, translational and clinical c . . .
* * *
Immunotherapy advances for AML, liver cancer and HPV-related cancers, plus findings related to TIL response, wound repair and proton therapy
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recently published studies in basic, translational and clinical c . . .